Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Induction vs. escalating therapy in multiple sclerosis: practical implications.

Giancarlo Comi1

  • 1Department of Neurology, Scientic Institute San Raffaele, Via Olgettina 60, 20132, Milano, Italy. comi.giancarlo@hsr.it

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|October 4, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis.

Cell death & disease·2018
Same author

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.

Neurology·2018
Same author

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks.

Neurology·2018
Same author

Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension study.

Therapeutic advances in neurological disorders·2018
Same author

Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Multiple sclerosis (Houndmills, Basingstoke, England)·2018
Same author

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2018
Same journal

Hypogonadotrophic hypogonadism in GBA2 associated spastic paraplegia type 46 (SPG46): a phenotypic expansion.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Vibrotactile stimulation induces changes in basal ganglia output, cervical muscle activity, and head posture in a patient with cervical dystonia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Evaluating LLM diagnostic reasoning: a new frontier for clinical AI assessment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Neuropsychological assessment in adult epilepsy: rationale, test selection, and clinical integration across non-surgical care in Italian patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Early implementation of transradial mechanical thrombectomy in a primary stroke center: a sequential cohort propensity score-matched study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Early treatment for Multiple Sclerosis (MS) using therapies like interferon-beta (IFNbeta) or glatiramer acetate (GA) is recommended to reduce relapses and inflammation. Aggressive induction therapy offers short- and long-term benefits, with escalation strategies for suboptimal control.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Multiple Sclerosis (MS) management often involves early therapeutic decisions.
  • Interferon-beta (IFNbeta) and glatiramer acetate (GA) are established early treatment options.
  • The 'treat-early' approach aims to reduce relapse rates and inflammatory processes.

Purpose of the Study:

  • To review the benefits of early therapeutic interventions in Multiple Sclerosis.
  • To discuss the role of induction and escalating therapy strategies.
  • To highlight the challenge of personalized drug selection in MS treatment.

Main Methods:

  • Review of current consensus guidelines and therapeutic strategies for MS.
  • Analysis of early treatment approaches with IFNbeta and GA.

Related Experiment Videos

  • Discussion of escalating therapies for suboptimal disease control.

    • Main Results:

    • Early treatment with IFNbeta or GA is supported by consensus groups for its benefits.
    • Induction therapy, particularly in early or high-risk MS, shows significant short- and long-lasting effects.
    • Escalation strategies involving various immunomodulatory agents are considered for uncontrolled disease.

    Conclusions:

    • Personalized drug selection is crucial for optimizing MS treatment outcomes.
    • Combination therapy should be considered promptly for patients with poor response to monotherapy.
    • Delaying combination therapy until irreversible disability occurs should be avoided.